E09.353 — Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula

Not billable

Is E09.353 billable?

No — E09.353 is a non-billable header code. E09.353 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 4 billable codes beneath E09.353.

Billable codes under this header

E09.3531Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye
E09.3532Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye
E09.3533Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral
E09.3539Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

E09.353 at a glance

Code	E09.353
Description	Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula
Billable	No — header code
Code set	ICD-10-CM FY2027
Valid for encounters	October 1, 2026 – September 30, 2027

How is E09.353 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to E09.353. They show the wording a clinician may have documented, which often differs from the Tabular description.

Diabetes, diabetic › due to drug or chemical › with › retinopathy › proliferative › with › traction retinal detachment not involving the macula (mellitus) (sugar)

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E09.353 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E09

The conditions below can never be reported together with E09.353 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

diabetes mellitus due to underlying condition (E08.-)
gestational diabetes (O24.4-)
neonatal diabetes mellitus (P70.2)
postpancreatectomy diabetes mellitus (E13.-)
postprocedural diabetes mellitus (E13.-)
secondary diabetes mellitus NEC (E13.-)
type 1 diabetes mellitus (E10.-)
type 2 diabetes mellitus (E11.-)

Code first — inherited from E09

The underlying condition below must be sequenced before E09.353. E09.353 describes a manifestation and cannot be the principal or first-listed diagnosis.

poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)

Use additional code — inherited from E09

Report an additional code alongside E09.353 to fully describe the condition. E09.353 is sequenced first.

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
code to identify control using:
injectable non-insulin antidiabetic drugs (Z79.85)
insulin (Z79.4)
oral antidiabetic drugs (Z79.84)
oral hypoglycemic drugs (Z79.84)

What codes fall under E09.353? (4)

How long has E09.353 existed?

E09.353 first appears in FY2018 (FY2017 is not available, so it may have appeared then).

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.